Skin Cancer Photos – Outbreaks and Early Detection by Type

Skin cancer is a disease that can be effectively treated when detected early, but may lead to serious consequences if diagnosis is delayed. For this reason, understanding how different types of skin cancer appear is crucial for recognizing suspicious changes in a timely manner. In this article, we comprehensively discuss various skin cancer images, key points to consider for early diagnosis, and which changes require evaluation by a dermatologist.

What Does Skin Cancer Look Like?

Skin cancer most commonly presents as a newly appearing lesion on the skin or as noticeable changes in the appearance of an existing mole. Irregular borders, asymmetry, multiple colors within the same lesion, shiny or pearly bumps, non-healing sores, and areas that crust or bleed from time to time are among the most common warning signs. Some types of skin cancer may progress silently and initially resemble a harmless spot or mild irritation. Therefore, while comparing suspicious lesions with skin cancer photos can be helpful for awareness, it is not sufficient for diagnosis. Any suspicious change requires professional dermatological evaluation.

Key Differences Between Skin Cancer and Benign Moles

The most important distinction between skin cancer and ordinary moles lies in the lesion’s behavior over time and its visual irregularities. Normal moles are typically symmetrical, uniform in color, and remain stable in size for many years. In contrast, skin cancer lesions often show asymmetry, irregular or blurred borders, multiple color tones, and rapid growth. Symptoms such as itching, bleeding, crusting, a non-healing wound appearance, or shiny, pearly nodules are also common warning signs.

The visual comparison of these features can help raise awareness; however, every new or changing skin lesion should be professionally assessed.

Early Skin Changes That May Be Noticed

In the early stages of skin cancer, changes are often subtle and easily overlooked, making careful observation essential. Warning signs may include asymmetric growth in a mole, darkening or lightening of color, surface roughness, or blurred borders. Additionally, small wounds that do not heal, mild crusting, recurrent bleeding, or lesions that resemble pimples but persist over time may also appear in early stages. These changes are often painless and therefore ignored, yet early detection significantly increases treatment success.

Signs That Appear in Advanced Stages

In advanced stages, skin cancer symptoms tend to become more pronounced and aggressive. Lesions that initially appear small and localized may grow rapidly, become raised, or spread into surrounding tissues. Non-healing open wounds, thick crusting, dark and irregular color patterns, along with redness, bleeding, pain, or tenderness may occur. In some cases, inflammation, swelling, or firm nodules may develop around the lesion. In more aggressive types such as melanoma, enlarged lymph nodes, signs of metastasis, and systemic symptoms can also be observed.

Common Types of Skin Cancer

Skin cancer can arise from different types of skin cells, resulting in diverse clinical appearances. Each type differs significantly in symptoms, progression rate, and risk level. The three most common types are Basal Cell Carcinoma (BCC), Squamous Cell Carcinoma (SCC), and Melanoma. BCC typically progresses slowly and is characterized by shiny or pearly bumps, while SCC often appears as crusted, rough, or wound-like lesions. Melanoma, the most aggressive form, is known for its irregular colors and asymmetry, making early diagnosis especially critical.

Basal Cell Carcinoma (The Most Common and Slowest-Growing Type)

Squamous Cell Carcinoma (A Redder and Scaly Appearance)

Squamous Cell Carcinoma (SCC) is a type of skin cancer that can progress more aggressively than basal cell carcinoma and most commonly develops in areas with intense sun exposure. It originates from squamous cells in the upper layer of the skin and often initially appears as a red, rough, and scaly patch. Over time, the lesion may thicken, form crusts, or take on the appearance of a non-healing wound. Some lesions may become tender to the touch or bleed intermittently, which is an important warning sign of SCC’s potential to progress. Visually, its firm and crusted surface clearly distinguishes it from BCC. While comparing such suspicious lesions with skin cancer photos can increase awareness, professional dermatological evaluation should not be delayed due to SCC’s higher risk of faster spread.

Melanoma (The Most Dangerous Type, but Treatable with Early Detection)

What Is Melanoma?

Melanoma is a type of skin cancer that develops as a result of the malignant transformation of cells called melanocytes, which produce the melanin pigment responsible for the color of the skin, hair, and eyes. Scientifically, melanoma is characterized by uncontrolled proliferation of melanocytes following DNA damage, invasion into surrounding tissues, and a high potential for metastasis. Its biological behavior is highly aggressive; although it may initially remain confined to the epidermis, it can progress over time into the dermis and lymphatic structures, spreading to distant organs. Genetic mutations (such as BRAF and NRAS), intense ultraviolet (UV) exposure, and environmental factors affecting melanocyte biology play a significant role in the development of melanoma. Therefore, melanoma is defined not merely as a pigment-related skin lesion, but as a malignant neoplasm originating from melanocytes.

Rare Types of Skin Cancer

Rare types of skin cancer include conditions such as Merkel cell carcinoma, Kaposi sarcoma, dermatofibrosarcoma protuberans (DFSP), and sebaceous carcinoma, which are often aggressive or difficult to diagnose. Each arises from different cell lineages and typically presents with atypical appearances that may be mistaken for an ordinary mole or simple redness. In such cases, symptoms often remain subtle until the disease reaches a more advanced stage.

Merkel Cell Tumors

Merkel cell tumors are a rare group of neuroendocrine tumors among skin cancers and are known for their highly aggressive behavior and rapid metastatic potential. Merkel cells are specialized cells located in the upper layer of the skin and play a role in the perception of touch; malignant transformation of these cells leads to tumor development.
Clinically, these tumors typically present as painless, rapidly growing, reddish-purple, dome-shaped nodules and are most commonly found on sun-exposed areas such as the face, ears, and neck. The risk is significantly higher in older individuals, those with weakened immune systems, and people with prolonged ultraviolet (UV) exposure. Early recognition of Merkel cell tumors is particularly challenging; therefore, while comparing suspicious nodules with skin cancer photos may increase awareness, a definitive diagnosis can only be made through biopsy and immunohistochemical analysis.

Kaposi Sarcoma

Kaposi Sarcoma is a malignant tumor originating from lymphatic endothelial cells and is commonly associated with infection by Human Herpesvirus 8 (HHV-8). It occurs more frequently in immunocompromised individuals, particularly patients with HIV/AIDS, organ transplant recipients, or those receiving immunosuppressive therapy. Clinically, it appears as purplish, reddish, or brownish patches, nodules, or plaques on the skin, which may gradually merge and spread over larger areas. Kaposi Sarcoma is a systemic disease that can affect not only the skin but also internal organs such as the lungs and the gastrointestinal tract. Because it can resemble other benign skin conditions in its early stages, it is often difficult to recognize promptly.

Sebaceous Gland Tumors and Cutaneous Lymphomas

Sebaceous gland tumors (sebaceous carcinoma) and cutaneous lymphomas (e.g., Mycosis Fungoides, Sézary syndrome) are two distinct groups of malignancies that, although rare, carry significant clinical importance. Sebaceous carcinoma typically arises from sebaceous glands around the eyelids and often initially appears as firm, yellowish, irregular nodules that may be mistaken for a chalazion or stye. This tumor can progress rapidly and has metastatic potential; if not recognized early, it may lead to severe local tissue destruction.

Cutaneous lymphomas, on the other hand, are cancers originating from T or B lymphocytes of the immune system. They may present on the skin as reddish patches, itchy plaques, thickened nodules, or widespread rashes. Over time, these lesions can evolve and progress through different clinical phases. Because both tumor types can initially resemble benign skin reactions, diagnosis may be delayed.

Lesion Examination with Dermoscopy

Dermoscopy is an imaging technique that plays a critical role in the early diagnosis of skin cancer by magnifying skin lesions and reducing surface reflections, allowing deeper structures to be visualized. Using this method, dermatologists can assess pigment distribution, vascular structures, border definition, and structural changes in the deeper layers of the skin in detail. Dermoscopy significantly improves diagnostic accuracy, particularly for cancers such as melanoma that are difficult to recognize in their early stages.

What Is Dermoscopy?

Dermoscopy is an optical imaging technique used in the diagnosis of cutaneous lesions, enabling in vivo evaluation of epidermal and superficial dermal structures under polarized or non-polarized light. The dermatoscope combines a lens system—typically providing 10–20× magnification—with a specialized illumination mechanism that eliminates surface reflections. This allows detailed analysis of morphological features not visible to the naked eye, such as pigment networks, vascular patterns, stromal changes, keratin structures, and structural asymmetries. The technique markedly increases diagnostic sensitivity, particularly in detecting subtle findings seen in early-stage melanoma, including atypical pigmentation, irregular reticular patterns, and microvascular abnormalities.

Dermoscopy Appearance of Melanoma

The dermoscopic appearance of melanoma is characterized by a series of atypical morphological features that distinguish it from benign pigmented lesions, and these findings are critically important for early diagnosis. On dermoscopy, melanoma typically shows asymmetric distribution of structures, an irregular pigment network, heterogeneous color patterns (with brown, black, gray, blue, and red tones present within the same lesion), and atypical dots and globules. In addition, features such as a blue-white veil, pseudopods, atypical radial streaks, and polymorphic vascular structures are considered high-risk indicators for melanoma. Regression areas observed at the periphery of the lesion, hypopigmented patches, or overall structural chaos are also important signs of malignant transformation. These dermoscopic characteristics clearly differ from the regular and homogeneous architecture seen in ordinary benign moles.

Distinctive Dermoscopic Patterns in Basal and Squamous Cell Tumors

Basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) display distinct yet diagnostically valuable dermoscopic patterns. In BCC, the most characteristic findings include arborizing (tree-like branching) telangiectasias, blue-gray ovoid nests, irregular pigmented clusters with disrupted structural symmetry, ulceration foci, and shiny white lines; these features reflect the tumor’s stromal structure and microvascular architecture.
In contrast, SCC and its precursor lesions such as actinic keratosis commonly show irregular keratin masses, white-yellow hyperkeratotic areas, glomerular vascular patterns, irregular dotted or ring-like vessels, and the coexistence of ulceration and crusting on the lesion surface. Vascular patterns in SCC are often polymorphic, reflecting the aggressive biological behavior of the malignancy.

Contact Us for Expert Evaluation

If you notice a suspicious skin lesion, accurate assessment and reliable medical guidance are essential. At QBA Medi Tours, we support you throughout dermatological diagnostic processes and, when necessary, in planning advanced diagnostic tests and treatment options. With our experienced team, we help you access Cuba’s advanced biotechnology-based treatment protocols and manage the process in the most appropriate way.

If you have questions about a suspicious skin change or an ongoing diagnostic process, you can contact us and receive personalized guidance from our professional healthcare consultants. Do not postpone your health.

Frequently Asked Questions

Can I diagnose skin cancer on my own by looking at skin cancer photos?

No. Skin cancer photos are intended only to raise awareness and help you recognize suspicious changes early; they do not allow for a definitive diagnosis. The color, structure, depth, and growth pattern of skin lesions can vary significantly from person to person. A confirmed diagnosis can only be made through a dermatological examination and, if necessary, a biopsy.

How can I tell if a mole has turned into skin cancer?

The most widely used method to evaluate whether a mole may have become cancerous is the ABCDE criteria.

• Asymmetry: One half of the mole does not match the other

• Border irregularity: Blurred, uneven, or notched edges

• Color variation: Multiple colors or uneven pigmentation within the same lesion

• Diameter: Larger than 6 mm

• Evolution: Noticeable changes over time

If any of these features are observed, dermatological evaluation should not be delayed.

How fast does skin cancer spread?

The rate of spread varies greatly depending on the type of skin cancer.

• Basal cell carcinoma usually grows very slowly and has a low risk of metastasis.

• Squamous cell carcinoma may grow more rapidly and can spread to lymph nodes.

• Melanoma is the most aggressive form and can quickly spread to deeper tissues and distant organs if not detected early.

For this reason, early diagnosis is critical.

At what age does skin cancer occur?

Skin cancer can occur at any age but is most commonly diagnosed in individuals over the age of 40 due to cumulative ultraviolet (UV) damage over time. However, intense sun exposure at a young age, tanning bed use, genetic predisposition, and fair skin can lead to earlier onset. Melanoma is one of the few cancers that can occur in young adults.

Does skin cancer cause itching?

Yes, some types of skin cancer may cause itching, stinging, burning, pain, or tenderness. However, many lesions develop without any symptoms. The absence of itching does not indicate safety; visual changes are always more significant than symptoms alone.

Where does skin cancer most commonly occur?

Skin cancer most frequently develops in sun-exposed areas such as the face, nose, ears, lips, neck, shoulders, back, and hands. However, certain types—especially melanoma—may also occur on areas with little sun exposure, including the trunk, legs, soles of the feet, or under the nails.

What can I do for self-examination at home?

• Regularly examine your entire body using a mirror

• Take note of any new or changing moles

• Photograph lesions to track changes (at intervals recommended by your doctor)

• Evaluate lesions using the ABCDE criteria

• Use sunscreen consistently and avoid tanning beds

Which lesions should be evaluated urgently by a doctor?

Lesions requiring urgent medical evaluation include those that grow rapidly, change shape, bleed, crust, or fail to heal. Multicolored or dark lesions with irregular borders, areas associated with pain, itching, burning, or tenderness, dark streaks or spots under the nails, and redness or swelling that persists after sunburn should also be promptly assessed by a medical professional.

Skin cancer treatment is increasingly incorporating immunotherapy and biotechnology-based approaches alongside conventional methods. For selected patient groups, Cuban cancer vaccines and complementary treatment options may be considered as immune-supportive strategies. One of the modern immunotherapy agents included in current cancer treatment protocols is Keytruda (pembrolizumab), which is used particularly in aggressive skin cancers such as melanoma.

References

Harrison, K., Graham, G., Solis, A., & Valladares, A. (2024). The accuracy of skin cancer detection rates with the implementation of dermoscopy among dermatology clinicians: A scoping review. Cureus, 16(4).
https://doi.org/10.7759/cureus.59970
(PDF: https://pmc.ncbi.nlm.nih.gov/articles/PMC11460753/)

Kato, J., Horimoto, K., Sakamoto, R., Tanioka, M., Nishikawa, Y., & Miyagawa, S. (2019). Dermoscopy of melanoma and non-melanoma skin cancers. Frontiers in Medicine, 6, 180.
https://doi.org/10.3389/fmed.2019.00180
(PDF: https://www.frontiersin.org/articles/10.3389/fmed.2019.00180/full)

Kittler, H., Lallas, A., Longo, C., Moscarella, E., & Argenziano, G. (2021). Evolution of the clinical, dermoscopic and pathologic criteria of melanoma diagnosis. Dermatology Practical & Conceptual, 11(3), e2021154.
https://doi.org/10.5826/dpc.1103a154
(PDF: https://pmc.ncbi.nlm.nih.gov/articles/PMC8366309/)

Mihulecea, C. R., Onisor, C., Susan, M., & Jianu, A. M. (2023). The many roles of dermoscopy in melanoma detection. Life, 13(2), 477.
https://doi.org/10.3390/life13020477
(PDF: https://www.mdpi.com/2075-1729/13/2/477)

Sánchez-Moreno, E. C., Ocampo-Candiani, J., & Herz-Ruelas, M. E. (2025). Non-melanoma skin cancer: Dermatoscopic diagnostic clues in Mexican individuals based on Fitzpatrick skin phototypes. Journal of Clinical Medicine, 14(9), 2966.
https://doi.org/10.3390/jcm14092966
(PDF: https://www.mdpi.com/2077-0383/14/9/2966)

Wu, X., Nguyen, B., & Pincus, L. (2015). Dermoscopy: Not just for dermatologists. The Permanente Journal, 19(4), 70–78.
https://doi.org/10.7812/TPP/14-237
(PDF: https://pmc.ncbi.nlm.nih.gov/articles/PMC6094650/)